545 filings
Page 8 of 28
8-K
g2a6fj6y05j1qj
12 Feb 18
Palatin Technologies, Inc. Reports Second Quarter
12:00am
CT ORDER
sajl0uvxdi
9 Jan 18
Confidential treatment order
12:00am
S-8
9ebyr
14 Nov 17
Registration of securities for employees
12:00am
8-K
qyg1y
13 Nov 17
Palatin Technologies, Inc. Reports First Quarter
12:00am
8-K
pcp23j6 43t
25 Sep 17
Results of Operations and Financial Condition
12:00am
8-K
2xw7dv91q ak
12 Sep 17
Palatin Technologies Announces Appointment of Anthony M. Manning, Ph.D. to
12:00am
8-K
cdv8ug9v
7 Sep 17
Palatin Technologies Announces Signing of Licensing Agreement with Fosun Pharma
12:00am
8-K
36f6wb6stedok6jc
8 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
xqiz28
16 May 17
Palatin Technologies, Inc. Reports Third Quarter
12:00am
DEFA14A
btgzji3dd3 5sjo9jv
28 Apr 17
Additional proxy soliciting materials
12:00am
CT ORDER
osexx7g6
6 Mar 17
Confidential treatment order
12:00am
8-K
1xyjufk jo1
9 Feb 17
Palatin Technologies, Inc. Reports Second Quarter
12:00am
8-K
6gyidavclc bj
3 Feb 17
Palatin Technologies Announces Closing of License Agreement
12:00am
8-K
472z4bgjs7p7w 7ks1z
9 Jan 17
Two Phase 3 trials completed for Rekynda; co-primary endpoints met
12:00am